Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.040
+0.250 (6.60%)
At close: Jun 26, 2026, 4:00 PM EDT
4.050
+0.010 (0.25%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Zentalis Pharmaceuticals stock have an average target of 7.00, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 73.27% from the current stock price of 4.04.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Zentalis Pharmaceuticals stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +122.77% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +147.52% | May 26, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Hold Maintains $4 | Hold | Maintains | $4 | -0.99% | May 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 | Hold | Maintains | $4 | -0.99% | May 13, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $5 | Hold | Reiterates | $5 | +23.76% | May 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
21.42M
EPS This Year
-1.74
from -1.80
EPS Next Year
-1.56
from -1.74
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 45.3M | |
| Avg | n/a | 21.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 417.5% |
| Avg | - | 259.3% |
| Low | - | 16.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.33 | -0.87 | |
| Avg | -1.74 | -1.56 | |
| Low | -2.19 | -2.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.